Latest filing published 28 Jun 2023 for Black Diamond Therapeutics, Inc., €153k.
David M. Epstein discloses dealings in 3 companies, chiefly Black Diamond Therapeutics, Inc., MetaStat, Inc. and OSI Pharmaceuticals Inc. Over a trading history stretching from 1 May 2010 to 27 June 2023, the count stands at 24 filings.
No open-market purchase appears, only 8 sales worth €1.4M. Outside the open market, there are 5 share grants and 5 option exercises. So far in 2023, the count stands at no purchases and 1 sale.
On 28 June 2023 came the latest disclosure, an open-market sale for €153k in Black Diamond Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations